Women's cancer rates are set to climb nearly six times faster than men's over the next 20 years, according to new figures released by Cancer Research UK.
The charity is predicting that United Kingdom cancer rates will climb by around half a percent for men and by around three percent for women, which means an extra 4.5 million women and 4.8 million men will be diagnosed with the disease by 2035.
Data published by Cancer Research UK showed that unhealthy lifestyles are contributing to a rise in cancer cases among both sexes, but women are bearing the brunt of the increase.
Professor Peter Johnson, chief clinician at Cancer Research UK, said: "After smoking, being overweight is the single biggest preventable cause of cancer and has been linked to 13 different types".
Cancer Research UK says an estimated 4.5 million women and 4.8 million men will be diagnosed with cancer over the next two decades. Cancer rates are clearly on the rise as it is the leading cause of death with approximately 15% of all deaths.
Breast, prostate, lung and bowel cancer are the most common cancers, accounting for more than half (53%) of new cases of cancer each year.
Some types of cancer only affect women and are linked to obesity.
What are the best ways to reduce the risk of cancer?
Based on the new findings it seems soy may not pose an extra risk for breast cancer development or recurrence, but with caveats.
Dr Smittenaar added: 'We haven't yet seen the peak in lung cancer cases among women, where it is already declining among men.
The Louisiana Cancer Foundation (LCF) presented ULM College of Pharmacy Professor Dr. Paul Sylvester with a check for $10,000 in continued support of his breast cancer research on January 26.
Smoking has been identified as a major factor why rates will rise faster in women. I was recently diagnosed with breast cancer and have completed radiation.
Baroness Delyth Morgan, chief executive at Breast Cancer Now, said: "This is the clearest illustration to date that the drug appraisal system is totally unfit for goal in assessing first-in-class breast cancer medicines".
The researchers found that 22.8 percent of breast cancers in this group could have been averted if obese and overweight women attained a body mass index of less than 25, the equivalent of 155lbs for a woman of 5 feet 6 inches.
"Palbociclib could benefit a large proportion of metastatic breast cancer patients and may even be the closest thing these women would have to a cure in their lifetime".
According to the researchers, Diacerin, which is used by Arthritis patients, can be used to combat breast cancer.
"If the manufacturer, Nice, and NHS England can find a way of making this treatment available for patients, they will substantially improve the lives of patients with breast cancer".